Medical/Pharmaceuticals
SteriLance Safety Lancets Adopted Across Thailand's Public-Hospital Channels
BANGKOK, Sept. 2, 2025 /PRNewswire/ -- SteriLance Medical announced that its safety lancet portfolio — PRESS PLUS, IMPRESS and LITE3 — has been adopted withinThailand's public-hospital channels following a tender awarded by a nationally recognized humanitarian organization. Supply and post-market...
LOTTE BIOLOGICS establishes contract manufacturing partnership with a leading U.S. Biopharmaceutical Company
Secures third contract this year, reinforcing global competitiveness and expanding strategic partnerships SEOUL, South Korea and SYRACUSE, N.Y., Sept. 2, 2025 /PRNewswire/ -- LOTTE BIOLOGICS (CEOJames Park) today announced that it has entered a late-stage to commercial contract manufacturing par...
Norma Completes Quantum AI Algorithm Validation on NVIDIA
"Quantum AI up to 73x Faster on NVIDIA CUDA-Q" * Norma, a quantum computing company, has validated the performance of quantum AI algorithms using NVIDIA CUDA-Q. * By running these algorithms for drug development on CUDA-Q, Norma observed computational speeds up to 73 times faster. * The com...
Data4Life announces the appointment of Dr. Ben Illigens as new CEO by the Hasso Plattner Foundation
POTSDAM, Germany, Sept. 1, 2025 /PRNewswire/ -- Data4Life announces that the Hasso Plattner Foundation, as the supporting foundation of the organization, has appointed Dr. Ben Illigens as its new Chief Executive Officer (CEO). He succeedsChristian Weiss, who has shaped the development phase of D...
Berlin Heals Holding AG Successfully Raises Over 5Million USD Round for Advancing New Less Invasive Approaches
ZUG, Switzerland, Sept. 1, 2025 /PRNewswire/ -- Berlin Heals Holding AG, a MedTech company, is developing a novel treatment to reverse remodel and recover from Heart Failure. After a successful First-In-Human study in 2019 followed by sustaining long-term results and a successful Randomized Contr...
Rosti to Showcase Next-Generation Medical Manufacturing Solutions at MedTec China 2025
SHANGHAI, Sept. 1, 2025 /PRNewswire/ -- Shanghai, September 24–26, 2025 – Stand 1D402 Rosti Integrated Manufacturing Solutions (Suzhou) Co., Ltd., part of the Rosti Group, will highlight its expanding medical device capabilities at MedTec China 2025, showcasing advanced medical injection mouldin...
CMEF 2025: Promoting Holistic and High-Quality Development of Medical and Health Industry
GUANGZHOU, China, Sept. 1, 2025 /PRNewswire/ -- The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is set to take place from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) inGuangzhou. Themed "Health, Innovation, Collaboration," ...
Jenscare Announces 2025H1 Interim Results
BEIJING, Sept. 1, 2025 /PRNewswire/ -- Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company dedicated to interventional treatment for structural heart diseases, achieved key milestones in its product portfolio and just announced its interi...
AbbVie Named to 2025 Best Workplaces in Asia List by Great Place To Work
SINGAPORE, Sept. 1, 2025 /PRNewswire/ -- Great Place To Work®, the global
authority on workplace culture, has selected AbbVie for the2025 Best Workplaces
in Asia™ List
The Veteran Suite partners with QENDO to advocate for female veteran care
SYDNEY, Sept. 1, 2025 /PRNewswire/ -- The Veteran Suite, a medical centre exclusively for Australian veterans and their families, has launched a new partnership with QENDO, an Australian organisation providing support and education for those affected by endometriosis, adenomyosis, PCOS, infertili...
LifeTech Scientific Corporation Announces 2025 Interim Results: Core Business Demonstrated Resilience, Domestic and Overseas Sales Both Increased
HONG KONG, Aug. 30, 2025 /PRNewswire/ -- LifeTech Scientific Corporation ("LifeTech" or the "Company", together with its subsidiaries, the "Group", stock code: 1302.HK), a medical device company specializing in minimally invasive interventional solutions for cardio-cerebrovascular and peripheral ...
Guo Guangchang: Fosun Strives to Break Through in Advantageous Sectors and Reach the Global Pinnacle
HONG KONG, Aug. 29, 2025 /PRNewswire/ -- On the morning of 29 August, Guo Guangchang, Chairman of Fosun International, stated at the Company's 2025 interim results presentation that Fosun will continue to increase investment in biopharmaceuticals and focus on deepening and thoroughly developing i...
MGI Tech and JCBio Announce Collaboration on DCS Lab Project to Advance Multi-Omics Innovation in South Korea
CHANGCHUN, China, Aug. 29, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation in life sciences, and JCBio Co., Ltd. ("JCBio"), a leading South Korean biotechnology company, have signed a Memorandum of Understanding ...
UCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress
* 26 scientific abstracts, including two oral presentations, demonstrate UCB's ongoing commitment to advancing research for people living with epilepsies * Data include an open-label extension study describing the long-term safety of FINTEPLA®▼ (fenfluramine)[1] and global functioning in chil...
Alphamab Oncology Reports 2025 Interim Results and Business Highlights
SUZHOU, China, Aug. 29, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) reported interim financial results for the six months endedJune 30, 2025 and highlighted recent business progress. Financial Summary * For the six months ended June 30, 2025, we recorded total revenue of RMB ...
Everest Medicines Announces Interim Results for First Half of 2025
SHANGHAI, Aug. 29, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, today announced its interim results for the first half of 2025 a...
Hua Medicine Announces 2025 Interim Results
* Sales of HuaTangNing (华堂宁®) increased by 108% year-on-year, with net sales increasing by 112% year-on-year. Reimbursement coverage continued to expand, with a significant increase in prescription volumes across Tier 2 and Tier 3 hospitals, as our comprehensive commercialization strategy achie...
Futurise Lead RegTalk 2025: AI Medical Devices in Malaysia - Balancing Innovation and Safety
CYBERJAYA, Malaysia, Aug. 28, 2025 /PRNewswire/ -- Futurise Sdn Bhd (Futurise), in collaboration with the Medical Device Authority (MDA), hosted the latest edition of RegTalk at the Siemens Healthineers Experience Center, focusing on "AI Medical Devices inMalaysia – Balancing Innovation & Safety....
ACROBiosystems and DAAN Biotherapeutics Sign Strategic MOU for the Development of Precision Immuno-Oncology Therapeutics
SEOUL, South Korea, Aug. 28, 2025 /PRNewswire/ -- ACROBiosystems, a global biotechnology company dedicated to accelerating the drug development process through innovative tools and solutions, announced that it has entered into a strategic Memorandum of Understanding (MOU) with DAAN Biotherapeutic...
AIM Vaccine Forecasts Surge in Stock Performance: Innovations Reinforce Leadership in Vaccine Sector
HONG KONG, Aug. 28, 2025 /PRNewswire/ -- AIM Vaccine (06660.HK), a leading domestic vaccine company, announced today the release of its 2025 interim report, showcasing robust revenue growth. With major products entering the market phase, R&D costs are decreasing, and operational expenditures are ...
Week's Top Stories
Most Reposted
Agoda Releases AI Developer Report 2026: Agentic AI Adoption Outpaces Enterprise Readiness Across Southeast Asia and India
[Picked up by 294 media titles]
2026-09-24 10:30Malaysia Calls for Shift from Halal-Certified to Halal-Competitive as ASEAN Targets USD5 Trillion Global Halal Economy
[Picked up by 277 media titles]
2026-09-25 14:45HLB's Flagship CIO Fund Launched with Strategic Alliance with Lombard Odier
[Picked up by 276 media titles]
2026-09-28 23:04Responsible Fintech Institute Appoints Four Executive Fellows and Elevates Distinguished Professor Patrick H. M. Loh to Co-Founder
[Picked up by 276 media titles]
2026-09-29 09:00DOKU Names Himelda Renuat CEO as Ant International's Antom Deepens Strategic Investment in Indonesia's Payments Leader
[Picked up by 274 media titles]
2026-09-24 10:00